Related Experiment Video
Updated: Dec 10, 2025

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Regen med therapeutic opportunities for fighting COVID-19
Anthony Atala1, Alicia Henn2, Martha Lundberg3
1Wake Forest Institute for Regenerative Medicine, Winston-Salem, North Carolina, USA.
Abstract:
This perspective from a Regenerative Medicine Manufacturing Society working group highlights regenerative medicine therapeutic opportunities for fighting COVID-19. This article addresses why SARS-CoV-2 is so different from other viruses and how regenerative medicine is poised to deliver new therapeutic opportunities to battle COVID-19. We describe animal models that depict the mechanism of action for COVID-19 and that may help identify new treatments. Additionally, organoid platforms that can recapitulate some of the physiological properties of human organ systems, such as the lungs and the heart, are discussed as potential platforms that may prove useful in rapidly screening new drugs and identifying at-risk patients. This article critically evaluates some of the promising regenerative medicine-based therapies for treating COVID-19 and presents some of the collective technologies and resources that the scientific community currently has available to confront this pandemic.
Insights
Regenerative medicine offers novel therapeutic strategies against COVID-19 by exploring unique viral mechanisms and utilizing advanced models. This approach aims to accelerate drug discovery and patient identification for better pandemic response.
Area of Science:
- Regenerative Medicine
- Virology
- Drug Discovery
Background:
- SARS-CoV-2 presents unique challenges compared to other viruses.
- The COVID-19 pandemic necessitates innovative therapeutic approaches.
- Regenerative medicine manufacturing offers potential solutions.
Purpose of the Study:
- To highlight regenerative medicine's therapeutic opportunities for COVID-19.
- To explain the unique characteristics of SARS-CoV-2.
- To review current and future regenerative medicine strategies for COVID-19 treatment.
Main Methods:
- Discussion of animal models to elucidate COVID-19 mechanisms of action.
- Exploration of organoid platforms for drug screening and patient stratification.
- Critical evaluation of promising regenerative medicine-based therapies.
Main Results:
- Animal models can help identify potential treatments for COVID-19.
- Organoid platforms show promise for rapid drug screening and identifying at-risk individuals.
- Regenerative medicine technologies offer a collective resource for pandemic response.
Conclusions:
- Regenerative medicine provides a powerful framework for developing novel COVID-19 therapies.
- Advanced models like organoids are crucial for accelerating research and treatment.
- Collaboration and utilization of existing technologies are key to combating the pandemic.
More Related Videos
11:13Adenoviral Gene Therapy for Diabetic Keratopathy: Effects on Wound Healing and Stem Cell Marker Expression in Human Organ-cultured Corneas and Limbal Epithelial Cells
Published on: April 7, 2016
07:50Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
iPS Cell Differentiation
Mesenchymal Stem Cells
Stem Cell Culture
Tissue Renewal without Stem Cells
However, failure of such a system...